EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Tumor-Infiltrating Mast Cells Enhance Neoadjuvant Therapy Efficacy in ESCC via Modulation of the Desmoplastic Microenvironment

Xing Cui, Xiangmei Zhang, Qi Zhao, Xin Chen, Ming He, Meng Zhang, Ruiling Yang, Jidong Zhao, Junfeng Liu

OncoTargets and Therapy · 2026-01 · Volume 19 · 1-15

DOI: 10.2147/ott.s564090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OncoTargets and Therapy, 2026-01. Verfasst von Xing Cui und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, People's Republic of China. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Neoadjuvant therapy is essential for locally advanced esophageal squamous cell carcinoma (ESCC), but its efficacy requires improvement. This study investigated the role of tumor-infiltrating mast cells (MCs) in treatment response and prognosis.

Methods

An integrated approach was employed, combining single-cell RNA sequencing of paired specimens from one ESCC patient pre- and post-neoadjuvant therapy, immunofluorescence analysis of a retrospective cohort of 68 treatment-naïve ESCC surgical specimens, bioinformatics analysis of public datasets, and in vitro mast cell activation assays.

Results

Single-cell sequencing revealed a post-therapy increase in the proportion of MCs among immune cells (4% to 12%), alongside an enriched inflammatory gene profile. In the cohort of 68 patients, higher MC density was associated with smaller tumor diameter (Pearson r = -0.32, p=0.007) and significantly better overall survival (36 vs 23.5 months, p=0.038). No such correlations were found for macrophages or CD8+ T cells. Bioinformatic analysis linked MCs to extracellular matrix and vascular smooth muscle regulation. Critically, high MC density combined with low desmoplasia or fibrosis identified patients with the most favorable prognosis. Phenotypically, MCs were predominantly non-degranulated in situ. In vitro, LPS activation (a non-degranulating signal) significantly upregulated CCL19 and other chemokines in mast cells. Furthermore, LPS was detected in the tumor stroma of 47.1% (32/68) of patients but not in normal mucosa.

Conclusion

The findings demonstrate that tumor-infiltrating MCs are associated with enhanced efficacy of neoadjuvant therapy and improved survival in ESCC. The mechanism may involve LPS-induced, non-degranulatory MC activation that modulates the desmoplastic microenvironment. Targeting this axis presents a promising strategy for ESCC treatment.

Schlagwörter

Stichwörter der Autor:innen

desmoplasiaefficacyneoadjuvant therapynon-degranulationtumor-infiltrating mast cells

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, People's Republic of China.
  • Cancer Institute of Hebei Province, Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, People's Republic of China.
  • Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance, Hebei Medical University, Shijiazhuang, 050017, People's Republic of China.
  • Department of Clinical Lab, Affiliated Hospital of Hebei University, Baoding, 071000, People's Republic of China.
  • Department of Breast Surgery, Handan Central Hospital, Handan, Hebei, 056000, People's Republic of China.

Zitieren

APA

Cui, X., Zhang, X., Zhao, Q., Chen, X., He, M., Zhang, M., Yang, R., Zhao, J., & Liu, J. (2026). Tumor-Infiltrating Mast Cells Enhance Neoadjuvant Therapy Efficacy in ESCC via Modulation of the Desmoplastic Microenvironment. OncoTargets and Therapy, Volume 19, 1-15. https://doi.org/10.2147/ott.s564090

Vancouver

Cui X, Zhang X, Zhao Q, Chen X, He M, Zhang M, et al. Tumor-Infiltrating Mast Cells Enhance Neoadjuvant Therapy Efficacy in ESCC via Modulation of the Desmoplastic Microenvironment. OncoTargets and Therapy. 2026;Volume 19:1-15. doi:10.2147/ott.s564090

BibTeX
@article{Cui2026,
  author = {Cui, Xing and Zhang, Xiangmei and Zhao, Qi and Chen, Xin and He, Ming and Zhang, Meng and Yang, Ruiling and Zhao, Jidong and Liu, Junfeng},
  title = {Tumor-Infiltrating Mast Cells Enhance Neoadjuvant Therapy Efficacy in ESCC via Modulation of the Desmoplastic Microenvironment},
  journal = {OncoTargets and Therapy},
  year = {2026},
  volume = {Volume 19},
  pages = {1--15},
  doi = {10.2147/ott.s564090}
}
Kostenlos starten →